Jia Yan, Ai Zhonghua, Zhu Xianglong, Che Zhuohang, Pratikshya Adhikari, Tang Songyuan, Zhang Qiong
Department of Reproductive Immunology, Sichuan Jinxin Xi'nan Women's and Children's Hospital, Chengdu, Sichuan, China.
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Front Med (Lausanne). 2024 Apr 16;11:1348733. doi: 10.3389/fmed.2024.1348733. eCollection 2024.
To investigate the predictors of clinical pregnancy and live birth rate in patients with recurrent embryo implantation failure (RIF) treated with fertilization-embryo transfer (IVF-ET) technique.
This retrospective cohort study was conducted in Jinjiang District Maternal and Child Health Hospital, Chengdu City, Sichuan Province, China. Patients were recruited who were enrolled at this hospital between November 1, 2019 and August 31, 2022, and who met the following criteria: a frozen embryo transfer (FET) at day 5 or 6 blastocyst stage was performed and the number of transfer cycles was not less than two. We collected information on age, height, weight, number of embryo transfer cycles, and information related to clinical outcomes. We used the group of patients who underwent ERA testing as the study group and those who underwent FET only as the control group, and matched baseline characteristics between the two groups by propensity score to make them comparable. We compared the differences in clinical outcomes between the two groups and further explored predictors of pregnancy and live birth using survival analysis and COX regression modeling.
The success rate of clinical pregnancy in RIF patients was 50.74% and the live birth rate was 33.09%. Patients in the FET group were less likely to achieve clinical pregnancy compared to the ERA group ( = 0.788, 95% 0.593-0.978, < 0.05). Patients with >3 previous implantation failures had a lower probability of achieving a clinical pregnancy ( = 0.058, 95% 0.026-0.128, < 0.05) and a lower likelihood of a live birth ( = 0.055, 95% 0.019-0.160, < 0.05), compared to patients with ≤3 previous implantation failures. Patients who had two embryos transferred were more likely to achieve a clinical pregnancy ( = 1.357, 95% 1.079-1.889, < 0.05) and a higher likelihood of a live birth ( = 1.845, 95% 1.170-2.910, < 0.05) than patients who had a single embryo transfer. Patients with concomitant high-quality embryo transfer were more likely to achieve a clinical pregnancy compared to those without high-quality embryo transfer ( = 1.917, 95% 1.225-1.863, < 0.05).
Not receiving an ERA, having >3 previous implantation failures, using single embryo transfer and not transferring quality embryos are predictors for clinical pregnancy in patients with RIF. Having>3 previous implantation failures and using single embryo transfer were predictors for live birth in patients with RIF.
探讨接受体外受精 - 胚胎移植(IVF - ET)技术治疗的反复胚胎植入失败(RIF)患者临床妊娠和活产率的预测因素。
本回顾性队列研究在四川省成都市锦江区妇幼保健院进行。招募2019年11月1日至2022年8月31日期间在该院就诊,且符合以下标准的患者:进行第5天或第6天囊胚期的冷冻胚胎移植(FET),且移植周期数不少于两个。收集年龄、身高、体重、胚胎移植周期数以及与临床结局相关的信息。将接受子宫内膜容受性检测(ERA)的患者组作为研究组,仅接受FET的患者作为对照组,通过倾向得分匹配两组的基线特征使其具有可比性。比较两组临床结局的差异,并使用生存分析和COX回归模型进一步探索妊娠和活产的预测因素。
RIF患者的临床妊娠成功率为50.74%,活产率为33.09%。与ERA组相比,FET组患者实现临床妊娠的可能性较小(= 0.788,95%置信区间0.593 - 0.978,< 0.05)。与既往植入失败≤3次的患者相比,既往植入失败> 3次的患者实现临床妊娠的概率较低(= 0.058,95%置信区间0.026 - 0.128,< 0.05),活产的可能性也较低(= 0.055,95%置信区间0.019 - 0.160,< 0.05)。与移植单个胚胎的患者相比,移植两个胚胎的患者更有可能实现临床妊娠(= 1.357,95%置信区间1.079 - 1.889,< 0.05),活产的可能性也更高(= 1.845,95%置信区间1.170 - 2.910,< 0.05)。与未进行优质胚胎移植的患者相比,进行优质胚胎移植的患者更有可能实现临床妊娠(= 1.917,95%置信区间1.225 - 1.863,< 0.05)。
未接受ERA检测、既往植入失败> 3次、采用单个胚胎移植以及未移植优质胚胎是RIF患者临床妊娠的预测因素。既往植入失败> 3次和采用单个胚胎移植是RIF患者活产的预测因素。